Does fecal secretory IgA increase during intestinal infection or dysbiosis?

Secretory IgA (sIgA) is the primary immunoglobulin providing immune exclusion at the mucosal surface. Its levels in the feces serve as a marker for the state of the intestinal immune environment, though its fluctuations depend heavily on the nature of the microbial challenge.

Clinical evidence of infection response

Fecal sIgA is a reliable indicator of mucosal immune activation during acute intestinal infections. Studies consistently show that the body upregulates sIgA production as a first-line defense against pathogens.

• Parasitic and Viral Infections: In cases of enterobiasis (pinworms) and ascariasis, infected individuals exhibit significantly higher fecal sIgA levels compared to healthy controls, with symptomatic patients showing the most pronounced elevations. Similarly, in rotavirus infections, high fecal sIgA levels are inversely correlated with viral load, reflecting an active and protective immune response.
• Bacterial Challenges: Pathogens such as C. difficile and Citrobacter rodentium trigger the production of pathogen-specific sIgA. This response is often mediated by cytokines like IL-17, which facilitates both the secretion of IgA and the subsequent clearance of the bacteria.

Impact of dysbiosis on sIgA levels

While infections typically cause a surge in sIgA, chronic intestinal dysbiosis is more commonly associated with a reduction in fecal sIgA rather than an elevation.

• Metabolic Signaling: Commensal bacteria produce short-chain fatty acids (SCFAs), such as acetate and butyrate, which are critical for IgA production. Acetate, for example, activates GPR43 on dendritic cells, which in turn promotes the differentiation of B-cells into IgA-secreting plasma cells.
• Immune Impairment: In dysbiotic states, the depletion of these beneficial microbes and their metabolites leads to a breakdown in this signaling pathway. This results in a weakened "IgA-biome" with reduced coating of intestinal microbes, potentially allowing for increased epithelial contact and inflammation. Evidence suggests that restorative treatments, such as fecal microbiota transplantation (FMT), act by increasing these deficient sIgA levels back to a healthy baseline.

Mechanistic explanations

The concentration of sIgA in the gut lumen is regulated by the recruitment of IgA-producing plasma cells to the lamina propria and the expression of the polymeric immunoglobulin receptor (pIgR) on intestinal epithelial cells.

• During infection, inflammatory signals and pathogen-associated molecular patterns (PAMPs) rapidly upregulate pIgR, facilitating the transcytosis of dimeric IgA into the lumen to neutralize the threat.
• In dysbiosis, the lack of positive microbial signals (like SCFAs) leads to a downregulation of these pathways, resulting in lower steady-state sIgA levels and a compromised mucosal barrier.

Bottom line

Fecal sIgA rises predictably during acute intestinal infections as part of a robust mucosal defense. However, in the context of dysbiosis, the evidence suggests that sIgA levels are more likely to be depleted due to a lack of beneficial microbial signaling, contradicting the idea that dysbiosis typically triggers an elevated sIgA response.